Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
UTMD Utah Medical Products
- 63.600
- -0.050-0.08%
Trading Dec 13 10:19 ET
215.71MMarket Cap14.86P/E (TTM)
63.910High63.360Low1.98KVolume63.650Open63.650Pre Close125.92KTurnover0.07%Turnover Ratio13.92P/E (Static)3.39MShares85.85952wk High1.74P/B186.18MFloat Cap63.00052wk Low1.20Dividend TTM2.93MShs Float126.334Historical High1.89%Div YieldTTM0.86%Amplitude2.826Historical Low63.598Avg Price1Lot Size
Utah Medical Products Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -19.99%10.01M | -19.17%10.4M | -9.42%11.34M | -3.93%50.22M | -9.14%12.33M | -3.47%12.51M | -4.19%12.87M | 1.60%12.52M | 6.58%52.28M | 5.11%13.57M |
| Operating revenue | -19.99%10.01M | -19.17%10.4M | -9.42%11.34M | -3.93%50.22M | -9.14%12.33M | -3.47%12.51M | -4.19%12.87M | 1.60%12.52M | 6.58%52.28M | 5.11%13.57M |
| Cost of revenue | -18.32%4.2M | -19.11%4.15M | -2.20%4.57M | 0.50%20.19M | -0.23%5.24M | 7.91%5.15M | -2.84%5.13M | -2.36%4.68M | 10.74%20.09M | 9.29%5.25M |
| Gross profit | -21.16%5.8M | -19.20%6.25M | -13.73%6.77M | -6.70%30.04M | -14.76%7.1M | -10.10%7.36M | -5.05%7.74M | 4.12%7.84M | 4.14%32.2M | 2.64%8.33M |
| Operating expense | -27.46%2.46M | -15.06%2.82M | -28.58%2.14M | 6.89%13.26M | -3.16%3.15M | 11.33%3.39M | 7.11%3.31M | -0.53%3M | 3.07%12.41M | 9.19%3.26M |
| Selling and administrative expenses | -29.67%2.29M | -19.52%2.56M | 8.39%1.37M | 6.61%12.7M | -4.02%3.01M | 10.88%3.25M | 7.50%3.18M | -56.27%1.26M | 3.49%11.91M | 10.27%3.13M |
| -Selling and marketing expense | ---- | ---- | 6.46%412K | 11.81%1.69M | ---- | ---- | ---- | --387K | 6.58%1.51M | ---- |
| -General and administrative expense | ---- | ---- | 9.25%957K | 5.86%11.02M | ---- | ---- | ---- | --876K | 3.06%10.41M | ---- |
| Research and development costs | 24.64%172K | 91.73%255K | 84.72%266K | 13.59%560K | 18.70%146K | 23.21%138K | -1.48%133K | 17.07%144K | -6.27%493K | -12.77%123K |
| Depreciation amortization depletion | ---- | ---- | -68.26%504K | ---- | ---- | ---- | ---- | --1.59M | ---- | ---- |
| -Depreciation and amortization | ---- | ---- | -68.26%504K | ---- | ---- | ---- | ---- | --1.59M | ---- | ---- |
| Operating profit | -15.77%3.34M | -22.31%3.44M | -4.56%4.63M | -15.22%16.78M | -22.21%3.94M | -22.80%3.97M | -12.50%4.43M | 7.21%4.85M | 4.82%19.79M | -1.17%5.07M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 2.96%836K | 3.48%773K | -36.53%172K | 281.13%3.31M | 105.95%1.07M | 310.10%812K | 426.06%747K | 3,287.50%271K | 380.11%869K | 921.57%521K |
| Gain on sale of security | ---- | ---- | ---- | 359.30%3.04M | ---- | ---- | ---- | ---- | 298.19%661K | ---- |
| Special income (charges) | ---- | ---- | -81.66%-743K | ---- | ---- | ---- | ---- | ---409K | ---- | ---- |
| -Less:Other special charges | ---- | ---- | 81.66%743K | ---- | ---- | ---- | ---- | --409K | ---- | ---- |
| Other non- operating income (expenses) | 2.96%836K | 3.48%773K | 34.56%915K | 32.69%276K | -1,302.14%-1.96M | 310.10%812K | 426.06%747K | 8,400.00%680K | 1,286.67%208K | -21.74%-140K |
| Income before tax | -12.59%4.18M | -18.58%4.21M | -6.27%4.8M | -2.76%20.09M | -10.27%5.02M | -10.45%4.78M | -0.52%5.17M | 13.00%5.12M | 8.38%20.66M | 7.91%5.59M |
| Income tax | -27.19%616K | -22.02%758K | -6.96%842K | -17.49%3.45M | -29.44%731K | -20.11%846K | -11.31%972K | -9.14%905K | -2.04%4.19M | -1.24%1.04M |
| Net income | -9.45%3.56M | -17.79%3.45M | -6.12%3.96M | 0.98%16.64M | -5.91%4.29M | -8.06%3.94M | 2.36%4.2M | 19.24%4.21M | 11.39%16.47M | 10.24%4.56M |
| Net income continuous Operations | -9.45%3.56M | -17.79%3.45M | -6.12%3.96M | 0.98%16.64M | -5.91%4.29M | -8.06%3.94M | 2.36%4.2M | 19.24%4.21M | 11.39%16.47M | 10.24%4.56M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -9.45%3.56M | -17.79%3.45M | -6.12%3.96M | 0.98%16.64M | -5.91%4.29M | -8.06%3.94M | 2.36%4.2M | 19.24%4.21M | 11.39%16.47M | 10.24%4.56M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -9.45%3.56M | -17.79%3.45M | -6.12%3.96M | 0.98%16.64M | -5.91%4.29M | -8.06%3.94M | 2.36%4.2M | 19.24%4.21M | 11.39%16.47M | 10.24%4.56M |
| Basic earnings per share | -5.56%1.02 | -15.52%0.98 | -6.03%1.09 | 1.10%4.58 | -5.94%1.181 | -8.47%1.08 | 2.65%1.16 | 19.59%1.16 | 11.85%4.53 | 11.08%1.2555 |
| Diluted earnings per share | -5.56%1.02 | -14.78%0.98 | -6.03%1.09 | 1.11%4.57 | -5.83%1.18 | -8.47%1.08 | 2.68%1.15 | 20.83%1.16 | 11.88%4.52 | 11.18%1.253 |
| Dividend per share | 1.69%0.3 | 1.69%0.3 | 1.69%0.3 | 1.72%1.185 | 1.69%0.3 | 1.72%0.295 | 1.72%0.295 | 1.72%0.295 | 36.26%1.165 | 0.295 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.